glp-1 in development History of Medications GLP-1s & Beyond: Understanding Incretin

Once you open the bottle, the clock starts

A recent study compared semaglutide and tirzepatide for weight loss and found that tirzepatide resulted in 2.4% more weight loss at 3 months, 4.3% more at 6 months, and 6.9% more at 12 months

Consider them your health journey BFFs who can help you navigate your results and support you along the way

Theoretically, nanoparticles (NPs) encapsulating GLP-1RAs can significantly extend the drugs half-life and promote accumulation of the drug in the joint cartilage, thereby maintaining a high therapeutic concentration for an extended period and improving treatment efficacy

Where the GLP-1 MDL stands now As of March 2026, the GLP-1 MDL is in the expert discovery phase

Data Integrity : Key Lessons from the 2025 FDA Warning Letters Data Integrity Is a Leadership Problem, Not a Regional One: Lessons from 2025 FDA Warning Letters Executive Summary This report provides an evaluation of US FDA Warning Letters issued in calendar year 2025 that cite 21 CFR 211.68(b), focusing on automated and computerized systems used to generate, process, store, and report CGMP data